Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, According to Spherix Global Insights EXTON, PA, July 18, 2024 (GLOBE NEWSWIRE) -- In February of this year, Takeda’s Eohilia (budesonide oral suspension) received FDA approval as the first and only oral therapy for eosinophilic...

Maryland’s Largest Independent GI Provider Announces Grand Re-Opening Near Bowie Silver Spring, MD, April 29, 2019 (GLOBE NEWSWIRE) -- Capital Digestive Care has announced it will reopen its Glenn Dale, MD office to serve patients in Prince George’s County.  Five of the area’s...